Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/20/202411:45AMGlobeNewswire Inc.BUREAU VERITAS: Assemblée générale ordinaire du 20 juin 2024 : Adoption de l'ensemble des résolutions proposéesEU:BVIBureau Veritas
06/20/202411:45AMGlobeNewswire Inc.Ipsos accélère le rythme de livraison de ses données avec la plateforme de DatasmoothieEU:IPSIpsos
06/20/202411:45AMGlobeNewswire Inc.Ipsos boosts speed of data delivery with Datasmoothie’s platformEU:IPSIpsos
06/20/202411:45AMGlobeNewswire Inc.BUREAU VERITAS: Assemblée générale ordinaire du 20 juin 2024 : Adoption de l'ensemble des résolutions proposéesTG:4BVBureau Veritas
06/20/202411:45AMGlobeNewswire Inc.LUMIBIRD : nombre d'actions au 31 mai 2024LSE:0FRIQuantel Sa
06/20/202411:45AMGlobeNewswire Inc.LUMIBIRD : nombre d'actions au 31 mai 2024EU:LBIRDLumibird
06/20/202411:45AMGlobeNewswire Inc.BUREAU VERITAS: Ordinary Shareholders’ Meeting of June 20, 2024: All submitted resolutions were adoptedEU:BVIBureau Veritas
06/20/202411:45AMGlobeNewswire Inc.Ipsos boosts speed of data delivery with Datasmoothie’s platformEU:IPSIpsos
06/20/202411:45AMGlobeNewswire Inc.Ipsos boosts speed of data delivery with Datasmoothie’s platformTG:IPZIpsos
06/20/202411:45AMGlobeNewswire Inc.Ipsos accélère le rythme de livraison de ses données avec la plateforme de DatasmoothieTG:IPZIpsos
06/20/202411:45AMGlobeNewswire Inc.BUREAU VERITAS: Ordinary Shareholders’ Meeting of June 20, 2024: All submitted resolutions were adoptedTG:4BVBureau Veritas
06/20/202411:44AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:SGGFFiPath Bloomberg Sugar Subindex Total Return ETN (PK)
06/20/202411:43AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
06/20/202411:41AMGlobeNewswire Inc.Sidetrade secures majority control of SHS Viveon AGEU:ALBFRSideTrade
06/20/202411:41AMGlobeNewswire Inc.Sidetrade obtient le contrôle majoritaire de SHS Viveon AGEU:ALBFRSideTrade
06/20/202411:41AMPR Newswire (US)ONE Brands Brings Reese's Peanut Butter Flavor to Protein Bars
06/20/202411:40AMGlobeNewswire Inc.Redwood Services Welcomes New Chief Marketing Officer
06/20/202411:39AMPR Newswire (US)Orion Names Ashley McDurmon President and CEO
06/20/202411:38AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:38AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:38AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:38AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
06/20/202411:38AMPR Newswire (US)Top Cloud Services Provider Announces 8th Enterprise Colocation Services Expansion in Hillsboro Data Center Market
06/20/202411:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation
06/20/202411:37AMGlobeNewswire Inc.Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintideTG:22ZZealand Pharma AS
06/20/202411:37AMGlobeNewswire Inc.Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide
06/20/202411:37AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HFWAHeritage Financial Corporation

Your Recent History

Delayed Upgrade Clock